Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI.
J Clin Med
; 10(22)2021 Nov 14.
Article
en En
| MEDLINE
| ID: mdl-34830567
ABSTRACT
Acute kidney injury (AKI) is common after cardiac surgery. To date, there are no specific pharmacological therapies. In this review, we summarise the existing evidence for prevention and management of cardiac surgery-associated AKI and outline areas for future research. Preoperatively, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers should be withheld and nephrotoxins should be avoided to reduce the risk. Intraoperative strategies include goal-directed therapy with individualised blood pressure management and administration of balanced fluids, the use of circuits with biocompatible coatings, application of minimally invasive extracorporeal circulation, and lung protective ventilation. Postoperative management should be in accordance with current KDIGO AKI recommendations.
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Guideline
/
Risk_factors_studies
Idioma:
En
Revista:
J Clin Med
Año:
2021
Tipo del documento:
Article